Cilastatin EP Impurity A (Mixture Of Diastereomers)
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-C160-003
- Formula
- C16H26N2O6S
- Family
- Cilastatin
- Synonyms
- Cilastatin Sulfoxide, Cilastatin EP Impurity A
Pharmaceutical analytical standards
Active ingredients, pharmacopoeial impurities, metabolites, nitrosamines and labelled standards.
Results 211-220 of 5,812
Cilastatin EP Impurity A HCl (Mixture Of Diastereomers)
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-C160-004
- Formula
- C16H26N2O6S·HCl
- Family
- Cilastatin
Cilastatin EP Impurity B (Mixture of Diastereomers)
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-C160-005
- Formula
- C21H34N2O6S
- Family
- Cilastatin
- Synonyms
- Cilastatin EP Impurity B
Cilastatin EP Impurity F (90%)
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-C160-008
- Formula
- C16H26N2O5S
- Family
- Cilastatin
- Synonyms
- Cilastatin EP Impurity F
Cilastatin EP Impurity G (90%)
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-C160-009
- Formula
- C16H26N2O5S
- Family
- Cilastatin
- Synonyms
- Cilastatin EP Impurity G
Cilastatin EP Impurity H
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-C160-010
- Formula
- C15H26N2O3S
- Family
- Cilastatin
Cilastatin EP Impurity H Sodium Salt
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-C160-011
- Formula
- C15H25N2NaO3S
- Family
- Cilastatin
Melphalan EP Impurity B DiHCl
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-M042-006
- Formula
- C13H18N2O3·2HCl
- Family
- Melphalan
Melphalan EP Impurity B HCl
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-M042-007
- Formula
- C13H18N2O3·HCl
- Family
- Melphalan
Melphalan EP Impurity D DiHCl
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-M042-009
- Formula
- C13H19ClN2O3·2HCl
- Family
- Melphalan
No product found: try the CAS, the code or a shorter name, or write to us and we will look for it.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.